Institutional Manager · CIK 0001802630
Soleus Capital Management, L.P.
GREENWICH, CT · File #028-20043
Latest AUM
$2.71B
Positions
95
Top-10 Concentration
55.1%
Filings
12
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202595 pos · $2.71B
- 13F HOLDINGS REPORTQ/E Sep 202588 pos · $1.99B
- 13F HOLDINGS REPORTQ/E Jun 202595 pos · $1.51B
- 13F HOLDINGS REPORTQ/E Mar 202575 pos · $1.39B
- 13F HOLDINGS REPORTQ/E Dec 202481 pos · $1.59B
- 13F HOLDINGS REPORTQ/E Sep 202487 pos · $1.29B
- 13F HOLDINGS REPORTQ/E Jun 202492 pos · $1.13B
- 13F HOLDINGS REPORTQ/E Mar 202491 pos · $1.35B
- 13F HOLDINGS REPORTQ/E Dec 202391 pos · $1.08B
- 13F HOLDINGS REPORTQ/E Sep 2023101 pos · $899.5M
- 13F HOLDINGS REPORTQ/E Jun 202377 pos · $965.7M
- 13F HOLDINGS REPORTQ/E Mar 202372 pos · $697.1M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 2,900,000 | $353.6M | 13.95% |
| 2 | KRYSTAL BIOTECH INC | KRYS | 941,059 | $232.0M | 9.15% |
| 3 | CELCUITY INC | CELC | 1,808,258 | $180.4M | 7.12% |
| 4 | NOVOCURE LTD | NVCR | 8,530,665 | $110.3M | 4.35% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 362,966 | $107.0M | 4.22% |
| 6 | TG THERAPEUTICS INC | TGTX | 3,139,312 | $93.6M | 3.69% |
| 7 | DEXCOM INC | DXCM | 1,297,094 | $86.1M | 3.40% |
| 8 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1,320,000 | $78.4M | 3.10% |
| 9 | GLOBUS MED INC | GMED | 887,000 | $77.4M | 3.06% |
| 10 | BETA BIONICS INC | BBNX | 2,534,565 | $77.2M | 3.05% |
| 11 | AMICUS THERAPEUTICS INC | FOLD | 5,207,284 | $74.2M | 2.93% |
| 12 | TWIST BIOSCIENCE CORP | TWST | 1,861,802 | $59.1M | 2.33% |
| 13 | ORGANOGENESIS HLDGS INC | ORGO | 9,985,951 | $51.7M | 2.04% |
| 14 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,247,110 | $47.2M | 1.86% |
| 15 | MIRUM PHARMACEUTICALS INC | MIRM | 573,614 | $45.3M | 1.79% |
| 16 | INSULET CORP | PODD | 150,000 | $42.6M | 1.68% |
| 17 | NEUROPACE INC | NPCE | 2,703,208 | $41.7M | 1.65% |
| 18 | AXOGEN INC | AXGN | 1,206,855 | $39.5M | 1.56% |
| 19 | ANI PHARMACEUTICALS INC | ANIP | 486,243 | $38.4M | 1.51% |
| 20 | ALKERMES PLC | ALKS | 1,322,364 | $37.0M | 1.46% |